Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Axalta to Acquire The CoverFlexx Group, a Leading Aftermarket Coatings Business Focused on Economy Customers in North America
-
Nano Dimension Announces Q1/2024 Conference Call to Discuss Quarterly Results
-
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
-
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
-
AHIMA and the Patient ID Now Coalition Spotlight Urgent Patient Safety Issue
-
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
-
SOUTHERN CALIFORNIA BANCORP AND CALIFORNIA BANCORP ANNOUNCE RECEIPT OF REGULATORY APPROVAL FOR MERGER OF EQUALS
-
Treasure Global Emerges as Exclusive Partner for AI Blockchain Wallet on Telegram, Spearheading Innovation in the Blockchain Industry
-
Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
-
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
-
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
-
Store Closing Sales Begin at Select Ted Baker Locations in the U.S. and Canada
-
Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA
-
Collegium Announces $35 Million Accelerated Share Repurchase Program
-
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
-
CareCloud Capital Structure Update
-
ArcScan's Insight® 100 Ophthalmic Ultrasound Imaging System Approved in China
-
Verde Bio and SensaSure Technologies Complete Merger to Create Premier Mineral Acquisitions Company
-
Expert Panel Review Further Validates Use of ZORYVE® (roflumilast) Topical Foam, 0.3% for Treatment of Seborrheic Dermatitis Across Diverse Hair Types Published in Journal of Clinical and Aesthetic D
-
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
-
Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
-
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
-
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
-
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Genius Group Schedules Full Year 2023 Earnings Call Thursday, May 16, 2024 at 8:30am ET
-
BairesDev CEO Recognized as a Technology Executive of the Year in 2024 American Business Awards®
-
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
XBP Europe Holdings, Inc. Reports First Quarter 2024 Results
-
Subsea 7 S.A. mandatory notification of share trades
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
Fairfax Announces Purchase of 275,000 Subordinate Voting Shares for Cancellation From Chairman and CEO, Prem Watsa
-
VITAS® Healthcare Names Four Leaders to Its Executive Team: Melad, Escueta, Dr. Loftis, Durkin
-
Earn Passive Gold with ShadowGold: The DeFi RWA Token Backed by Physical Gold
-
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
-
Alm. Brand A/S – Weekly report on share buybacks
-
Spectral Medical Announces First Quarter Results and Provides Corporate Update
-
CLM Announces Management and Board Changes
-
Alaska Energy Metals Advances Core Asset Focus With Sale of Mexico Subsidiary and Shareholding
-
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Leading Independent Proxy Advisory Firm ISS Recommends Shareholders Vote “FOR” All of Crown Castle’s Director Nominees
-
Aqua-Tots Swim School Gets Ready to Jump into Lakeside Community in Forsyth County, Georgia
-
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
-
DeFi Technologies Subsidiary Valour Inc. Launches Internet Computer (ICP) and Toncoin (TON) ETPs, Landmark Offerings in the Nordics Alongside Chainlink (LINK) ETP
-
Enovix Begins Customer Sampling of EX-1M Batteries
-
MacroGenics to Participate in Upcoming Investor Conferences
-
MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
-
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at ESC-HF, Including That Acoramidis Treatment Significantl
-
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
-
Akoustis Reports Third Quarter FY24 Results


